which also goes by the name sotatercept, was originally picked up via Merck’s $11.5 billion acquisition of Acceleron back in 2021. The U.K.’s Medicines and Healthcare products Regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback